Section Arrow
ASMB.NASDAQ
- Assembly Biosciences
Quotes are at least 15-min delayed:2024/05/16 14:51 EDT
Last
 14.9115
+0.3015 (+2.06%)
Day High 
15.155 
Prev. Close
14.61 
1-M High
14.96 
Volume 
19.77K 
Bid
14.61
Ask
14.94
Day Low
14.3 
Open
14.3 
1-M Low
12 
Market Cap 
80.55M 
Currency USD 
P/E -- 
%Yield
10-SMA 13.26 
20-SMA 13.2 
50-SMA 13.3 
52-W High 20.04 
52-W Low 7.692 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-10.58/-8.00
Enterprise Value
81.67M
Balance Sheet
Book Value Per Share
5.91
Cash Flow
Cash Flow Yield
0.39
Income Statement
Total Revenue
7.16M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.098549+0.020849+26.83%-- 
NBYNovaBay Pharmaceuticals0.1179+0.0134+12.82%-- 
DNAGinkgo Bioworks Holdings0.8233-0.0158-1.88%-- 
JAGXJaguar Health0.2816+0.0265+10.39%-- 
NVAXNovavax14.5701+1.6701+12.95%-- 
Quotes are at least 15-min delayed:2024/05/16 14:51 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenueis generated from the HBV cure program.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.